Search

Displaying results 8611 - 8620 of 10000 in total
  1. Drug

    ATX-01

    go.drugbank.com/drugs/DB18141
    Investigational

    ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).

  2. Drug

    RP-A601

    go.drugbank.com/drugs/DB18339
    Investigational

    RP-A601 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene

  3. Drug

    FBX-101

    go.drugbank.com/drugs/DB18340
    Investigational

    FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene

  4. Drug

    Bindarit

    go.drugbank.com/drugs/DB12739
    Investigational

    Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

  5. Drug

    DTP-348

    go.drugbank.com/drugs/DB12741
    Investigational

    Dtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms.

  6. Drug

    Albusomatropin

    go.drugbank.com/drugs/DB12950
    Investigational

    Albusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.

    Synonyms: HUMAN SERUM ALBUMIN FUSED TO THE N-TERMINUS OF GROWTH HORMONE
  7. Drug

    Mitoguazone

    go.drugbank.com/drugs/DB12967
    Investigational

    Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

  8. Drug

    CHS-828

    go.drugbank.com/drugs/DB12980
    Investigational

    CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  9. Drug

    Filibuvir

    go.drugbank.com/drugs/DB11878
    Investigational

    Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.

  10. Drug

    Faropenem

    go.drugbank.com/drugs/DB12190
    Investigational

    Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.